login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IGM BIOSCIENCES INC (IGMS) Stock News
USA
- NASDAQ:IGMS -
US4495851085
-
Common Stock
1.27
USD
-0.03 (-2.31%)
Last: 8/13/2025, 8:15:46 PM
1.28
USD
+0.01 (+0.79%)
After Hours:
8/13/2025, 8:15:46 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IGMS Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: Zacks Investment Research
- Mentions:
TNGX
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
4 months ago - By: Yahoo Finance
- Mentions:
CON
Concentra Group (CON) to Acquire IGM Biosciences
4 months ago - By: Halper Sadeh LLC
- Mentions:
OLO
SPTN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OLO, SPTN, IGMS on Behalf of Shareholders
a year ago - By: Investor's Business Daily
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
a year ago - By: Benzinga
- Mentions:
NFE
CAPR
PMTS
UXIN
...
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
4 months ago - By: Halper Sadeh LLC
IGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to Shareholders
4 months ago - By: IGM Biosciences, Inc.
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
4 months ago - By: IGM Biosciences, Inc.
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
5 months ago - By: Yahoo Finance
- Mentions:
FIS
AAPL
IGM Biosciences price target lowered to $1 from $2 at Truist
6 months ago - By: Zacks Investment Research
- Mentions:
MRSN
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
OBIO
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: Zacks Investment Research
- Mentions:
GLUE
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
9 months ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS
10 months ago - By: Benzinga
- Mentions:
DAL
MCY
WBA
SVV
...
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
10 months ago - By: IGM Biosciences, Inc.
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
10 months ago - By: IGM Biosciences, Inc.
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences to Present at Three Upcoming Investor Conferences
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences to Present at Three Upcoming Investor Conferences
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
a year ago - By: IGM Biosciences, Inc.
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
Please enable JavaScript to continue using this application.